Japanese dentists are now paying far more for palladium, a rare earth metal that is an essential ingredient for making dental crowns, due to economic sanctions imposed against Russia due to its Ukraine invasion.
Russia accounts for about 40 percent of the global palladium production.
The price of the alloy containing palladium has skyrocketed over fears of supply chain disruptions as a result of the sanctions.
In mid-December, the purchase price of palladium per 30 grams was 77,770 yen ($653), including tax. As of March 9, the price of palladium per 30 grams had surged to 125,400 yen.
According to Toshiaki Tanaka, a director of the prefectural association of doctors and dentists in Kanagawa, the dentists are not being reimbursed for their additional costs under the national medical insurance system.
Dentists prefer an alloy of gold, silver, and palladium in fashioning a dental crown due to the alloy’s strength and durability when patients want treatment covered by national health insurance.
Dental crowns that do not contain palladium are not as strong and tend to discolor over time.
Medical institutions do not get reimbursed in medical fees due to a rise in materials when they give treatment covered by the national health program because the fees are fixed.
The current material fee for the alloy using palladium is 88,530 yen per 30 grams even after the purchase price increased by 30,000 yen.
Tanaka expressed concern that the increased cost may prompt some people to put off going to a dentist, even though they are in desperate need of treatment, and called on the government to take emergency steps to resolve the problem. He suggested that a provision like a government subsidy to rein in gasoline prices be made available for palladium.


The four types of dementia most people don’t know exist
Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Gold Price Ends Lower for Fourth Week Despite Rebound as Fed Rate Hike Bets Strengthen
OpenAI IPO Delay Weighs on SoftBank Shares as AI Valuation Concerns Grow
Asian Markets Rally as Micron and Qualcomm AI Outlook Lifts Global Tech Stocks
Wall Street Ends Mixed as Micron Surges, Apple Drops After Price Hikes
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
S&P Affirms Brazil’s BB Credit Rating with Stable Outlook Amid Fiscal Challenges
US Dollar Slips After PCE Inflation Data as Fed Rate Hike Expectations Stay Elevated
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 



